Treatment of mild and moderate hypertension with diltiazem 240 mg. Brazilian multicenter trial;Tratamento da hipertensao arterial leve e moderada com diltiazem 240 mg. Estudo multicentrico Brasileiro

Arquivos Brasileiros de Cardiologia

Volumn 66, Issue 6, 1996, Pages 365-369

  Santello, José Luiz ^a  

^a NONE

Author keywords

diltiazem; hypertension; treatment

Indexed keywords

DILTIAZEM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; DRUG EFFECT; DRUG TOLERANCE; MIDDLE AGED; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE; DILTIAZEM; DRUG TOLERANCE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030155036     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Joint National Committee - The 1988 report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1988; 148: 1023-8.
2. DeQuattro V - Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists. Clin Exp Hypertens 1994; 16: 853-64.
3. Zanchetti A - Short and long-term perspective of antihypertensive therapy. Am J Hypertens 1993; 6(suppl 2): 1-19.
4. Yedinak KC - Use of calcium channel antagonists for cardiovascular disease. Am Pharm 1993; 533: 49-64.